Equities

Vimta Labs Ltd

VIMTALABS:NSI

Vimta Labs Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)563.65
  • Today's Change-6.35 / -1.11%
  • Shares traded122.54k
  • 1 Year change+4.77%
  • Beta1.1138
Data delayed at least 15 minutes, as of Sep 20 2024 11:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments247377107
Total Receivables, Net996804771
Total Inventory276262207
Prepaid expenses303534
Other current assets, total27159124
Total current assets1,5761,6371,244
Property, plant & equipment, net2,1501,6931,501
Goodwill, net565656
Intangibles, net91122134
Long term investments--3125
Note receivable - long term221885
Other long term assets28237.72
Total assets4,0013,6233,072
LIABILITIES
Accounts payable82144123
Accrued expenses--00.06
Notes payable/short-term debt5103.19
Current portion long-term debt/capital leases505164
Other current liabilities, total357377287
Total current liabilities541573477
Total long term debt9199127
Total debt192150193
Deferred income tax0.780.690.74
Minority interest------
Other liabilities, total171133127
Total liabilities804805732
SHAREHOLDERS EQUITY
Common stock444444
Additional paid-in capital792780774
Retained earnings (accumulated deficit)2,3822,0121,540
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(21)(19)(18)
Total equity3,1972,8182,340
Total liabilities & shareholders' equity4,0013,6233,072
Total common shares outstanding222222
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.